SCHEMBL1609676

SCHEMBL1609676

CCN(Cc1ccccc1F)c1nc(C2CC2)nc(C(=O)OC)c1Cl

nearest known ligand 0.37

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TP53 P04637 2/20 0.37
LMNA P02545 2/20 0.37
MAPT P10636 2/20 0.37
ALDH1A1 P00352 6/20 0.35
SMN1; SMN2 Q16637 3/20 0.35
HTT P42858 1/20 0.35
TDP1 Q9NUW8 1/20 0.34
HSD17B10 Q99714 1/20 0.34
PGR P06401 1/20 0.34
CYP2D6 P10635 1/20 0.34
CYP2C9 P11712 1/20 0.34
CHRM5 P08912 1/20 0.33
HSP90AA1 P07900 1/20 0.33
HSP90B1 P14625 1/20 0.33
MEN1 O00255 1/20 0.33
KMT2A Q03164 1/20 0.33
L3MBTL1 Q9Y468 1/20 0.33
TSHR P16473 1/20 0.33
MAPK1 P28482 1/20 0.33
HCAR3 P49019 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1611310 0.93 TP53 (0.36) TP53LMNAMAPTALDH1A1SMN1; SMN2
SCHEMBL1609999 0.89 ALOX5 (0.34) TP53LMNAMAPTALDH1A1SMN1; SMN2
SCHEMBL12713240 0.88 CHRM3 (0.39) TP53LMNAMAPTALDH1A1SMN1; SMN2
SCHEMBL1610349 0.87 MAPT (0.41) TP53LMNAMAPTALDH1A1SMN1; SMN2
SCHEMBL12712701 0.86 CHRM3 (0.41) TP53LMNAMAPTALDH1A1SMN1; SMN2
SCHEMBL1609557 0.84 CNR2 (0.34) ALDH1A1MEN1KMT2A
SCHEMBL1609835 0.83 L3MBTL1 (0.36) LMNAMAPTALDH1A1SMN1; SMN2HSD17B10
SCHEMBL1609736 0.81 PDE10A (0.40) LMNAMAPTALDH1A1SMN1; SMN2HTT
SCHEMBL1610384 0.81 CHRM3 (0.37) LMNAMAPTALDH1A1SMN1; SMN2HTT
SCHEMBL1609836 0.81 ALDH1A1 (0.38) TP53LMNAMAPTALDH1A1SMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20110086759-A1 CHEMICAL COMPOUNDS SYNGENTA CROP PROTECTION, INC. (US) 2011-04-14 US disclosed
US-20110086759-A1 CHEMICAL COMPOUNDS SYNGENTA CROP PROTECTION, INC. (US) 2011-04-14 US disclosed
US-20110086759-A1 CHEMICAL COMPOUNDS SYNGENTA CROP PROTECTION, INC. (US) 2011-04-14 US disclosed
WO-2009081112-A2 CHEMICAL COMPOUNDS SYNGENTA LIMITED (GB) 2009-07-02 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110086759-A1 CHEMICAL COMPOUNDS DDT, PNPO, CBR3 TP53 731/4885LMNA 4805/4885MAPT 2800/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.